AIBT
AIBOTICS, INC.Company Information
- Company Name
- AIBOTICS, INC.
- CIK
- CIK0001763329
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- AIBT: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2833
- SIC Description
- Medicinal Chemicals & Botanical Products
- Ticker
- AIBT
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-19
- Price on filing date
- —
- 1-month reaction
- 137.50%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Preferred Stock | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Series A Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Receivables | - | - | - | 0 | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | - | - | ||||||
| Inventory Net | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
Assets Noncurrent | ||||||||||||||||||
| Property Plant And Equipment Net | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Intangible Assets Net Including Goodwill | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | - | ||||||
| Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 0 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
Liabilities Current | ||||||||||||||||||
| Accrued Liabilities And Other Liabilities | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Liabilities Current | - | - | - | - | - | - | - | - | - | - | 4 | 2 | ||||||
| Convertible Debt Current | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Accrued Liabilities Current | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Convertible Debt | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Convertible Notes Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | ||||||
| Liabilities | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 2 | ||||||
Temporary Equity | ||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -5 | -4 | -4 | -4 | -4 | -4 | -3 | -3 | -3 | -2 | -2 | -2 | ||||||
| Common Stock Value | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 9 | 9 | 9 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
| Retained Earnings Accumulated Deficit | -14 | -13 | -13 | -12 | -12 | -11 | -11 | -10 | -10 | -9 | -9 | -9 | ||||||
| Liabilities And Stockholders Equity | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 0 | ||||||
| Convertible Debt Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Temporary Equity Shares Authorized | - | - | - | - | - | - | - | - | 5 | 5 | 5 | 5 | ||||||
| Temporary Equity Shares Outstanding | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | - | - | 5 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 7,500 | 7,500 | 7,500 | 467 | 467 | 7,500 | 467 | 467 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 723 | 539 | 487 | 319 | 52 | 45 | 40 | 5 | 15 | 15 | 15 | 15 | ||||||
| Shares Outstanding | 723 | 539 | 487 | 319 | 52 | 45 | 40 | 5 | 15 | 15 | 15 | 15 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAIBOTICS, INC. (AIBT) — SEC Financial Statements & Analysis
AIBOTICS, INC. (AIBT) is a medicinal chemicals & botanical products company, incorporated in NV. AIBOTICS, INC. trades on OTC as: AIBT. AIBOTICS, INC. (AIBT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19. Based on that filing, AIBOTICS, INC. carries a market cap of $433.50K, a P/E ratio of -0.21x, a P/B ratio of -0.09x, a P/S ratio of 557.60x, an enterprise value of $1.33M, and an EV/EBITDA multiple of -0.77x. On profitability, it posts an operating margin of -84501.74%, a net margin of -101500.27%, a Return on Equity (ROE) of 47.52%, and a Return on Assets (ROA) of -241.27%. Per share, it reports EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 3.16% year-over-year, and EPS growth of -92.63% year-over-year. On the balance sheet, it maintains a current ratio of 0.07x, a quick ratio of 0.07x, working capital of $-3.97M, a debt-to-equity ratio of -2.09x, a debt ratio of 1.91, an interest coverage ratio of -8.62x, free cash flow of $-348.60K (TTM), and net debt of $891.86K. Figures sourced from SEC EDGAR.
- Market Cap
- $433.50K
- P/E TTM
- -0.21x
- EPS TTM
- $-0.00
- P/B TTM
- -0.09x
- ROE TTM
- 47.52%
- ROA TTM
- -241.27%
- Debt To Equity
- -2.09x
- Free Cash Flow TTM
- $-348.60K
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is AIBOTICS, INC. in?
AIBOTICS, INC. (AIBT) operates in the Medicinal Chemicals & Botanical Products industry.
What exchange does AIBT trade on?
AIBOTICS, INC. (AIBT) trades on the OTC.
Where is AIBOTICS, INC. incorporated?
AIBOTICS, INC. is incorporated in NV.
When was AIBOTICS, INC. (AIBT)'s most recent SEC filing?
AIBOTICS, INC. (AIBT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19.
What is AIBT's market cap?
AIBOTICS, INC. (AIBT) has a market capitalization of $433.50K as of 2026-06-30.
What is AIBT's EPS (earnings per share)?
AIBOTICS, INC. (AIBT)'s trailing twelve month EPS is $-0.00 as of 2026-06-30.
What is AIBT's ROE (return on equity)?
AIBOTICS, INC. (AIBT)'s trailing twelve month Return on Equity (ROE) is 47.52% as of 2026-06-30.
What is AIBT's ROA (return on assets)?
AIBOTICS, INC. (AIBT)'s trailing twelve month Return on Assets (ROA) is -241.27% as of 2026-06-30.
What is AIBT's EV/EBITDA?
AIBOTICS, INC. (AIBT)'s trailing twelve month EV/EBITDA is -0.77x as of 2026-06-30.